Streptogramin-based gene regulation systems for mammalian cells

被引:197
作者
Fussenegger, M [1 ]
Morris, RP
Fux, C
Rimann, M
von Stockar, B
Thompson, CJ
Bailey, JE
机构
[1] ETH Zurich, Swiss Fed Inst Technol, Inst Biotechnol, CH-8093 Zurich, Switzerland
[2] Univ Basel, Bioctr, Dept Microbiol, CH-4056 Basel, Switzerland
关键词
gene therapy; tissue engineering; Streptomyces; Synercid; erythropoietin;
D O I
10.1038/81208
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Here we describe repressible (PipOFF) as well as inducible (PipON) systems for regulated gene expression in mammalian cells, based on the repressor Pip (pristinamycin-induced protein), which is encoded by the streptogramin resistance operon of Streptomyces coelicolor. Expression of genes placed under control of these systems was responsive to clinically approved antibiotics belonging to the streptogramin group (pristinamycin, virginiamycin, and Synercid). The versatility of these systems was demonstrated by streptogramin-regulated expression of mouse erythropoietin (EPO), human placental secreted alkaline phosphatase (SEAP), or green fluorescent protein (GFP) in diverse cell lines (BHK, CHO, HeLa, and mouse myoblasts). Analysis of isogenic constructs in CHO cells demonstrated the PipOFF system gave lower background and higher induction ratios than the widely used tetracycline-repressible (TetOFF) expression systems. The streptogramin-based expression technology was functionally compatible with the TetOFF system, thus enabling the selective use of different antibiotics to independently control two different gene activities in the same cell.
引用
收藏
页码:1203 / 1208
页数:6
相关论文
共 34 条